NACDS has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues.
NACDS RxIMPACT pharmacy advocates are urging Senators to sign a letter to U.S. Secretary of Health and Human Services Secretary Alex Azar that is being led by Sen. Shelley Moore Capito (R-WV) and Sen. Jon Tester (D-MT).
CMS signals potential action on DIR fee reform, takes action on NACDS-backed strategy to help address opioid abuse epidemic.
NACDS expressed support for, and provided further input, on CMS’ proposed rule, which involves issues including direct and indirect remuneration fees; e-prescribing; medication therapy management; opioid abuse; and fostering pharmacy access.
E-prescribing, opioid issues, medication therapy management, pharmacy access addressed by Centers for Medicare & Medicaid Services.
NACDS print ads, and Coalition radio and digital ads, are running in selected Congressional Districts this August to tout the Pharmacy and Medically Underserved Areas Enhancement Act.
NACDS strongly supports a Senate letter sent to Health and Human Services (HHS) Secretary Tom Price and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma on the use of direct and indirect remuneration (DIR) fees.
NACDS-backed bipartisan provider status legislation—H.R. 592—got a boost from the Americans for Tax Reform (ATR) recently in a letter to Rep. Brett Guthrie (R-KY) stating that the bill could streamline the healthcare system, improve access to care for patients and result in billions of dollars in savings.
NACDS welcomed members of the NACDS Board of Directors for a two-day Washington fly-in this week as an increasingly intense debate on healthcare continues to reverberate on the Hill and across the country.
Arlington, VA – In a column published in today’s print and online editions of The Hill, the National Association of Chain Drug Stores (NACDS) positioned pharmacy patient care and collaboration across […]